Innovative test that detects complex DNA patterns may improve mesothelioma detection rate in blood

by Susan Murphy,Mayo ClinicStudy design. Our study involved detecting junctions that result from chromosomal rearrangements, insertions and deletions in mesothelioma in Step 1, then designing pr

Updated on: December 02,2024

Innovative test that detects complex DNA patterns may improve mesothelioma detection rate in blood

by Susan Murphy,Mayo ClinicStudy design. Our study involved detecting junctions that result from chromosomal rearrangements, insertions and deletions in mesothelioma in Step 1, then designing pr

Updated on:December 02,2024

'Masked' cancer drug stealthily trains immune system to kill tumors while sparing healthy tissues

by Aslan Mansurov,The ConversationDendritic cells (green) produce cytokines like IL-12, which can train T cells (pink) to attack tumors. Credit:Victor Segura Ibarra and Rita Serda/National

Updated on: March 30,2024

'Masked' cancer drug stealthily trains immune system to kill tumors while sparing healthy tissues

by Aslan Mansurov,The ConversationDendritic cells (green) produce cytokines like IL-12, which can train T cells (pink) to attack tumors. Credit:Victor Segura Ibarra and Rita Serda/National

Updated on:March 30,2024

Harms reporting is inconsistent across organ cancer guidelines

byAmerican College of PhysiciansCredit: CC0 Public DomainA review of 33 organ-specific cancer screening guidelines has found that the reporting of harms related to screening tests and procedures

Updated on: December 22,2023

Harms reporting is inconsistent across organ cancer guidelines

byAmerican College of PhysiciansCredit: CC0 Public DomainA review of 33 organ-specific cancer screening guidelines has found that the reporting of harms related to screening tests and procedures

Updated on:December 22,2023

Unveiling the non-canonical functions of EZH2 in prostate cancer

by Impact Journals LLCProstate cancer cells. Credit: NIH Image GalleryA new editorial paper was published inOncotargettitled "Unveiling the non-canonical functions of EZH2 in prostate

Updated on: December 26,2023

Unveiling the non-canonical functions of EZH2 in prostate cancer

by Impact Journals LLCProstate cancer cells. Credit: NIH Image GalleryA new editorial paper was published inOncotargettitled "Unveiling the non-canonical functions of EZH2 in prostate

Updated on:December 26,2023

Major response to immunotherapy in early-stage mismatch repair deficient colon cancer

byEuropean Society for Medical OncologyCredit:Annals of OncologyPre-operative treatment with a combination of the immune checkpoint inhibitors nivolumab and ipilimumab achieves major patho

Updated on: December 18,2023

Major response to immunotherapy in early-stage mismatch repair deficient colon cancer

byEuropean Society for Medical OncologyCredit:Annals of OncologyPre-operative treatment with a combination of the immune checkpoint inhibitors nivolumab and ipilimumab achieves major patho

Updated on:December 18,2023

Genetic test could guide use of cancer chemotherapy

by Ellie Cawthera,Imperial College LondonDiscovery ofKRASG12mutation status as potential biomarker of outcome of FTD/TPI treatment in mCRC.a, Dot plot showing the associations

Updated on: December 25,2023

Genetic test could guide use of cancer chemotherapy

by Ellie Cawthera,Imperial College LondonDiscovery ofKRASG12mutation status as potential biomarker of outcome of FTD/TPI treatment in mCRC.a, Dot plot showing the associations

Updated on:December 25,2023

Integrating mental health services into oncology treatment protocols

byThe City University of New YorkStudy participant is interviewed. Credit: The City University of New YorkA new study by CUNY SPH doctoral student Thinh Vu and colleagues reveals that cancer inp

Updated on: December 26,2023

Integrating mental health services into oncology treatment protocols

byThe City University of New YorkStudy participant is interviewed. Credit: The City University of New YorkA new study by CUNY SPH doctoral student Thinh Vu and colleagues reveals that cancer inp

Updated on:December 26,2023

A blood sample 24 hours after the start of chemotherapy can predict survival

byUniversity of BergenMass cytometry analysis of early response evaluation by single-cell signaling to profile.aPeripheral blood samples were collected from 32 AML patients treated w

Updated on: December 25,2023

A blood sample 24 hours after the start of chemotherapy can predict survival

byUniversity of BergenMass cytometry analysis of early response evaluation by single-cell signaling to profile.aPeripheral blood samples were collected from 32 AML patients treated w

Updated on:December 25,2023

How the environment is silently shaping cancer risk: Data helps untangle links between pollution and cancer

by Niyati Jain,University of ChicagoDifferential expression of gene pathways in BCC (in blue) compared to healthy skin tissue (in red) by PTCH1 mutational status. BCC tissues with no non-synonym

Updated on: December 01,2024

How the environment is silently shaping cancer risk: Data helps untangle links between pollution and cancer

by Niyati Jain,University of ChicagoDifferential expression of gene pathways in BCC (in blue) compared to healthy skin tissue (in red) by PTCH1 mutational status. BCC tissues with no non-synonym

Updated on:December 01,2024

Trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainA Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment wi

Updated on: January 04,2024

Trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainA Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment wi

Updated on:January 04,2024

Public insurance tied to lower cancer survival in young patients

(HealthDay)—Young, low-income patients with bone or soft tissue sarcomas have decreased overall survival (OS), regardless of disease stage at presentation, according to a study published online Dec. 1

Updated on: December 22,2023

Public insurance tied to lower cancer survival in young patients

(HealthDay)—Young, low-income patients with bone or soft tissue sarcomas have decreased overall survival (OS), regardless of disease stage at presentation, according to a study published online Dec. 1

Updated on:December 22,2023

Model illuminates environmental cues that may contribute to breast cancer recurrence

by Karen B. Roberts,University of DelawareUniversity of Delaware post-doctoral researcher Lina Pradham loads a protocol and plate into a bioprinter made by Inventia. Called the RASTRUM, the Inve

Updated on: December 22,2023

Model illuminates environmental cues that may contribute to breast cancer recurrence

by Karen B. Roberts,University of DelawareUniversity of Delaware post-doctoral researcher Lina Pradham loads a protocol and plate into a bioprinter made by Inventia. Called the RASTRUM, the Inve

Updated on:December 22,2023